Softwr

AI · head to head

LatchBio vs Proxmox VE

LatchBio logo

LatchBio

AI

AI agents that run bioinformatics analyses, from a company that pivoted from workflow hosting

From
On request
Free plan
No
Full reviewWebsite
Proxmox VE logo

Proxmox VE

Cloud

Open-source hypervisor combining KVM and LXC virtualisation

From
€120/year
Free plan
No
Full reviewWebsite

The short version

  • Each has a real cost: LatchBio the company has pivoted from hosted bioinformatics workflows to AI agents, so organisations that adopted the earlier SDK and workflow product are now on a line that is no longer the strategic focus.; Proxmox VE per-socket licensing model: cost scales with CPU socket count, not vCore count, resulting in high costs for multi-socket servers
  • Prices and features above were last checked on 31 August 2026.

Where they differ

Only the attributes on which LatchBio and Proxmox VE actually diverge.

Attributes where LatchBio and Proxmox VE differ
AttributeLatchBioProxmox VE
Starting priceOn request€120/year
Pricing modelquotesubscription
PlatformsWebLinux, Web, API, Self-hosted
CategoryAICloud

Identical on both: free tier (No), user rating (Not yet rated).

What each one covers

Drawn from each product's published feature list. An absence here means we hold no record of it - not that the product lacks it.

Only in LatchBio

  • Agent driven analysis
  • Multi assay support
  • Published benchmarks
  • White labelled portals
  • Common file format handling
  • Managed compute

Only in Proxmox VE

Nothing recorded that LatchBio does not also cover.

What people use each for

The jobs each tool is most often brought in to do.

LatchBio

  • A small biotech with sequencing data and no bioinformatician who needs a first pass differential expression or cell type annotation quicklynot Proxmox VE
  • An assay or kit vendor that wants to give customers an analysis portal under its own branding rather than shipping raw filesnot Proxmox VE
  • A wet lab scientist who wants to explore a dataset interactively before commissioning a formal analysis from a core facilitynot Proxmox VE
  • A research group benchmarking agent produced analyses against its own established pipeline to decide how much routine work can be delegatednot Proxmox VE

Proxmox VE

  • Open-source datacenter virtualisation for hosting providers and cloud platformsnot LatchBio
  • Cost-sensitive enterprise virtualisation replacing commercial hypervisorsnot LatchBio
  • High-availability clustering for disaster recovery and business continuitynot LatchBio
  • Container deployments using LXC as lighter-weight alternative to Dockernot LatchBio
  • Hybrid VM and container workloads in a single management interfacenot LatchBio
  • Backup and archival infrastructure alongside primary virtualisationnot LatchBio

Where each one falls short

Documented limitations, not opinions. Every one is a constraint you would hit in normal use.

LatchBio

  • The company has pivoted from hosted bioinformatics workflows to AI agents, so organisations that adopted the earlier SDK and workflow product are now on a line that is no longer the strategic focus.
  • Agent generated analysis code has to be validated by someone who could have written it, which inverts the value proposition for the small labs that most need it and cannot check the output.
  • No pricing is published, so the cost of routine agent analysis at team scale cannot be estimated without contacting sales, and compute billed through the platform makes the bill usage dependent.
  • Regulated use is a poor fit: an agent that writes non deterministic analysis code is difficult to validate under GxP, so this is a research tool rather than something that will sit in a regulated diagnostic or submission workflow.
  • The vendor publishes its own benchmarks, which is more than most competitors do, but self reported benchmarks on selected datasets are not a substitute for testing the agent on your own data before committing.

Proxmox VE

  • Per-socket licensing model: cost scales with CPU socket count, not vCore count, resulting in high costs for multi-socket servers
  • Linux-based host only; Windows hypervisors not supported, limiting adoption in Windows-focused organisations
  • Clustering and high-availability setup requires operational expertise and careful network configuration
  • Commercial support tiers limit advanced features (just-in-time access, network flow logs) to paid subscriptions
  • Smaller ecosystem of third-party plugins and integrations compared to VMware vSphere

Pricing, plan by plan

LatchBio

On request
  • LatchBio Platform$undefined/year
    • Quoted through a sales process
    • Interactive sandbox available for trying the agent before contracting
    • Enterprise and white labelled portal deployments priced separately

Proxmox VE

€120/year
  • Community$120/year
    • Enterprise Repository access
    • Community forum support only
    • Per-socket subscription model
  • Basic$370/year
    • 3 support tickets per year
    • 1 business day response time
    • Stable updates and Enterprise Repository
  • Standard$550/year
    • 10 support tickets per year
    • 4-hour response time for critical issues
    • Remote SSH support and offline updates
  • Premium$1100/year
    • Unlimited support tickets
    • 2-hour response time for critical issues
    • Remote SSH support and offline updates

Which should you pick?

Choose LatchBio if

  • You need agent driven analysis.
  • You also want multi assay support.
LatchBio review

Choose Proxmox VE if

  • You work on Linux, Web, API, Self-hosted.
Proxmox VE review

Questions people ask

Is LatchBio or Proxmox VE better?
Neither clearly leads. LatchBio starts at On request and Proxmox VE at €120/year, and user ratings are close enough to be indistinguishable. Choose on capability and platform support.
Which is cheaper, LatchBio or Proxmox VE?
LatchBio starts at On request and Proxmox VE at €120/year.
Does LatchBio or Proxmox VE run on more platforms?
LatchBio runs on Web. Proxmox VE runs on Linux, Web, API, Self-hosted.
What is LatchBio best used for?
LatchBio is most often used for a small biotech with sequencing data and no bioinformatician who needs a first pass differential expression or cell type annotation quickly, an assay or kit vendor that wants to give customers an analysis portal under its own branding rather than shipping raw files, a wet lab scientist who wants to explore a dataset interactively before commissioning a formal analysis from a core facility, a research group benchmarking agent produced analyses against its own established pipeline to decide how much routine work can be delegated. Of those, a small biotech with sequencing data and no bioinformatician who needs a first pass differential expression or cell type annotation quickly and an assay or kit vendor that wants to give customers an analysis portal under its own branding rather than shipping raw files are not what Proxmox VE is typically brought in for.
What can LatchBio do that Proxmox VE cannot?
LatchBio covers Agent driven analysis, Multi assay support, Published benchmarks, White labelled portals.

Answered from the vendors’ own pages

LatchBio: Is LatchBio still selling the original workflow platform?

The company is now led by agent.bio and its agent products. Buyers evaluating the older Python SDK workflow platform should confirm current support directly.

Proxmox VE: What is the licensing model for Proxmox VE?

Proxmox VE is open-source and free to deploy. Optional subscription tiers provide technical support, priority response times, and access to the Enterprise Repository for stable update channels. All tiers include identical virtualisation features.

Source
LatchBio: Can I try it before buying?

Yes. There is an interactive sandbox where you can upload data and run the agent before entering a sales conversation.

Proxmox VE: Can I run Proxmox VE without a support subscription?

Yes. Community Edition (€120/year per socket) provides Enterprise Repository access with community-based support through forums. The core Proxmox VE platform is fully functional without any subscription.

Source
LatchBio: Is it suitable for regulated work?

Not really. Non deterministic agent generated code is hard to validate under GxP, so treat it as a research and exploration tool.

Proxmox VE: What hypervisors does Proxmox VE support?

Proxmox VE includes both KVM for full virtualisation and LXC for Linux containers. It does not support Xen or Hyper-V. Workloads on those platforms must be migrated or reimplemented.

Source
LatchBio: What data types does it handle?

Single cell RNA sequencing, spatial transcriptomics, epigenomics, proteomics and pharmacology data, ingesting FastQ, H5AD and spreadsheet formats.

Share

Related pages

More on LatchBio

More on Proxmox VE

Keep looking

Other head to heads